ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.26
+4.16%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- 38.21x
- PEG TTM
- —
- Price / book
- 0.84x
- Price / sales
- 1.50x
- Price / cash flow
- -2.29x
Enterprise value
- Enterprise value
- -$85.0M
- EV / sales
- -0.27x
- EV / EBITDA
- -21.79x
- EV / EBIT
- 6.03x
- Market cap
- $474.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026